AJP - Endo Journal of Applied Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 272: E83-E85, 1997;
0193-1849/97 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mock, D. M.
Right arrow Articles by Heird, G. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mock, D. M.
Right arrow Articles by Heird, G. M.

AJP - Endocrinology and Metabolism, Vol 272, Issue 1 E83-E85, Copyright © 1997 by American Physiological Society


ARTICLES

Urinary biotin analogs increase in humans during chronic supplementation: the analogs are biotin metabolites

D. M. Mock and G. M. Heird
Department of Pediatrics, University of Arkansas for Medical Sciences, Arkansas Children's Hospital, Little Rock 72202-3591, USA.

In human subjects, the metabolic origins of bisnorbiotin and biotin sulfoxide were determined by measuring the urinary excretion of each after chronic administration of large oral doses of biotin. For 2 wk, 14 adult volunteers consumed 1,200 micrograms of biotin per day, an amount approximately 20 times the daily dietary intake. With the use of a high-performance liquid chromatography/avidin-binding assay in untimed urine samples obtained before the first dose of biotin and after the 14th dose, concentrations of biotin, bisnorbiotin, and biotin sulfoxide were measured. Excretion was expressed as concentration ratios to urinary creatinine. Bisnorbiotin and biotin sulfoxide excretion increased 85-fold (P < 0.0001) and 114-fold (P < 0.0001), respectively. The molar percentages of bisnorbiotin and biotin sulfoxide decreased from 28 to 14% (P = 0.006) and from 9 to 5% (P = 0.017), respectively. These data provide evidence that the bisnorbiotin and biotin sulfoxide found in human urine are biotin metabolites. Furthermore, we infer that chronic consumption of large amounts of biotin does not substantially saturate the human biotin pathways of biotransformation.


This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
S. C. Rathman, B. Lewis, and R. J. McMahon
Acute glucocorticoid treatment increases urinary biotin excretion and serum biotin
Am J Physiol Endocrinol Metab, March 1, 2002; 282(3): E643 - E649.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
B. Lewis, S. Rathman, and R. McMahon
Dietary Biotin Intake Modulates the Pool of Free and Protein-Bound Biotin in Rat Liver
J. Nutr., September 1, 2001; 131(9): 2310 - 2315.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
D. M. Mock, J. O. Nyalala, and R. M. Raguseo
A Direct Streptavidin-Binding Assay Does Not Accurately Quantitate Biotin in Human Urine
J. Nutr., August 1, 2001; 131(8): 2208 - 2214.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
D. M. Mock
Biotin Status: Which Are Valid Indicators and How Do We Know?
J. Nutr., February 1, 1999; 129(2): 498 - 498.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online